EB-1B Green Card for New York's Outstanding Researchers
EB-1B is the fastest employer-sponsored green card for research scientists and faculty — no PERM required. Columbia, NYU, Rockefeller, MSK, Weill Cornell, and Mount Sinai file EB-1B regularly for researchers and faculty on permanent tracks.
New York City's medical research corridor generates more EB-1B petitions than any US metro except the Boston-Cambridge area. Columbia University Irving Medical Center, NYU Langone, Weill Cornell Medicine, Mount Sinai's Icahn School, and Memorial Sloan Kettering Cancer Center all maintain established immigration infrastructure specifically for EB-1B sponsorship of permanent research faculty and scientists. EB-1B eliminates PERM labor certification for permanent research roles — the single most significant procedural advantage for institutions that want to move quickly on retaining talent.
Rockefeller University is exceptional within the NYC landscape. It is a research-only institution where essentially all faculty are active principal investigators. There are no administrative or teaching tracks; every appointment is research-based and permanent-eligible. Rockefeller has a decades-long record of EB-1B approvals at USCIS Nebraska Service Center, and the institutional immigration office processes these filings with efficiency. MSK is similarly distinctive: a dedicated immigration team within MSK HR handles EB-1B for both clinical investigators and basic scientists, with structured timelines from offer letter to I-140 filing that are faster than most peer institutions.
Outside the traditional academic medical center model, the Alexandria Center for Life Science cluster at East River Science Park has created a growing biotech EB-1B market. Scientists at clinical-stage biotechs with permanent research positions, patent records, and peer-reviewed publications are filing EB-1B through company counsel, outside the academic immigration infrastructure entirely.
Key institutions
Where New York EB-1B petitions originate.
These institutions and research employers generate the largest share of NYC EB-1B petitions. Notes reflect EB-1B sponsorship practices at each.
Columbia University & CUIMC
Top-5 NIH-funded private medical school; Office of International Students and Scholars (OISS) handles EB-1B for permanent faculty; CUIMC immigration team experienced across basic science and clinical research departments; outside counsel commonly engaged for parallel EB-1A self-petition.
NYU & NYU Langone Medical Center
NYU OISS handles EB-1B for permanent Langone faculty and Courant Institute researchers; institutional sponsorship requires permanent position confirmation; outside counsel frequently retained for complex profiles or EB-1A parallel filings not handled by institutional office.
Rockefeller University
Research-only institution; all faculty are active PIs; dedicated immigration office with decades of EB-1B history at Nebraska Service Center; institutional office processes EB-1B in-house; many researchers independently retain outside counsel for parallel EB-1A self-petition.
Memorial Sloan Kettering Cancer Center
Dedicated immigration team within MSK HR; structured EB-1B process for both clinical investigators and basic scientists; faster institutional timeline than most peer medical centers; outside counsel engaged for EB-1A parallel filings; strong oncology research publication record supports both pathways.
Weill Cornell Medicine & Mount Sinai
Both sponsor EB-1B for permanent faculty and research scientists; Icahn School at Mount Sinai among top-20 NIH-funded; active research programs in genomics, immunology, and cardiovascular science; outside counsel adds value for researchers who want to pursue EB-1A in parallel to institution's sponsored EB-1B.
Alexandria Center Biotech & NYC Life Sciences
Clinical-stage biotechs at East River Science Park with permanent research scientist positions; patent records, trade press coverage, and peer-reviewed publication records support EB-1B without the academic infrastructure; company counsel handles petitions; faster than PERM-based EB-2 for qualified scientists.
Eligibility
EB-1B criteria for NYC researchers.
EB-1B requires at least two of six regulatory criteria, plus a permanent job offer from a qualifying employer. For NYC research scientists and faculty, these four criteria are most commonly met:
01
Receipt of major prizes or awards for outstanding achievement
Named awards: NCI Outstanding Investigator Award, NIH Director's Pioneer Award, New Innovator Award, Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease, Searle Scholar, Sloan Research Fellowship, Howard Hughes Medical Institute Investigator. Editorial board memberships at top journals and invited plenary lectures at international conferences also contribute evidence of international recognition.
02
Scholarly articles in professional journals
Nature, Science, Cell, NEJM, JAMA, PNAS; first-authorship and corresponding-authorship; citation counts and h-index relative to field norms at the researcher's career stage. NYC medical journals frequently cited: Journal of Clinical Oncology for MSK researchers, Brain and Neurology for Columbia and NYU neurologists. The total citation record and evidence of field impact typically matter more than raw publication count.
03
Critical or leading role at a distinguished research institution
PI of a named laboratory; department section chief; senior investigator leading a defined research program; confirmed through institutional org chart, grant records showing PI status, and letters from department chairs. For EB-1B, the offer letter confirming the permanent appointment is required evidence; the role's indispensability and the institution's distinction must both be documented independently.
04
Other contributions of major significance to the field
Peer review history for Nature, Science, Cell, and NEJM; NIH and NCI study section or ad hoc review service; mentorship of postdocs and graduate students documented through lab records; conference organizing roles; patent filings with evidence of clinical-stage adoption. NYC researchers frequently have extensive peer review records they have not systematically documented for a petition.
New York EB-1B profiles
What qualifying records look like here.
Representative profiles from New York EB-1B petitions. Identifying details have been generalized.
Assistant Professor
NYU Grossman School of Medicine (Biochemistry & Molecular Pharmacology)
Structural basis of G-protein coupled receptor signaling
21 publications; 3 first-author in Nature and Nature Chemical Biology
NIH R01 (PI); Searle Scholar Award
Reviewer for Nature, Nature Chemistry, PNAS, and Science Signaling
NYU sponsored EB-1B for this permanent faculty appointment. Standard processing used; I-140 approved in 8 months.
Research Investigator
Memorial Sloan Kettering (Cancer Biology & Genetics)
Tumor suppressor mechanisms in colorectal cancer
19 publications; h-index of 16; NCI R01 (PI)
MSK Cancer Center Support Grant co-investigator
Reviewer for Cancer Research, Cancer Cell, and Oncogene
Invited speaker at AACR and ASCO Annual Meetings
MSK sponsored through dedicated immigration office. Permanent research scientist appointment confirmed via offer letter. PERM not required — EB-1B filed directly.
Associate Professor & HHMI Investigator
Rockefeller University (Laboratory of Biochemistry and Structural Biology)
Protein quality control and chaperone-mediated autophagy
38 publications; h-index of 27; Howard Hughes Medical Institute Investigator (2021)
Corresponding author on Nature Cell Biology, Journal of Cell Biology, and Developmental Cell
Reviewer for Nature, Cell, and EMBO Journal; session chair at ASCB Annual Meeting
Rockefeller sponsored EB-1B. Petitioner simultaneously filed self-petitioned EB-1A as backup. EB-1B approved in 9 months; EB-1A pending.
Choosing between pathways
EB-1B vs. EB-1A for NYC researchers.
EB-1B and EB-1A are not mutually exclusive, and NYC research institutions understand this. Columbia, NYU, and MSK routinely sponsor EB-1B while allowing researchers to file self-petitioned EB-1A in parallel through outside counsel. Two I-140s mean two priority dates and two approval tracks — whichever is approved first and reaches a current date first proceeds to I-485.
EB-1B is generally easier to qualify for because it requires only two of six criteria (versus three of ten for EB-1A) and does not require a finding of sustained national or international acclaim. For researchers at early-career or mid-career stages whose record is strong but not yet EB-1A-level, EB-1B sponsored by the institution is often the faster first path to a green card. The institution's involvement is required, however — EB-1B cannot be self-petitioned. For researchers at institutions unwilling to sponsor, or whose current appointment is a postdoc or fixed-term role, EB-2 NIW self-petition may be the interim strategy while building toward EB-1A.
FAQ
New York EB-1B questions.
Yes. EB-1B requires employer sponsorship and a permanent job offer — it cannot be self-petitioned. At NYC's major research institutions (Columbia, NYU, Rockefeller, MSK, Weill Cornell, Mount Sinai), EB-1B sponsorship for permanent faculty and research scientists is standard. If your current position is a postdoc or fixed-term appointment, the first step is negotiating conversion to a permanent research scientist or junior faculty appointment that enables sponsorship.
Both can serve as EB-1B petitioners — any employer that has a permanent position to offer can file. The "distinguished organization" question is answered similarly: MSK, Columbia, NYU, and Rockefeller are all clearly distinguished. The practical difference is the immigration infrastructure: Rockefeller and MSK have dedicated immigration offices; Columbia and NYU process through OIS. Outside counsel working alongside the institutional office can add value for complex profiles or cases where the institution is uncertain about the threshold.
Institutional immigration offices are conservative — they often decline petitions they're uncertain about to protect the institution's filing record. Outside counsel with independent experience at Nebraska Service Center can review the same record with different risk tolerance and may reach a different conclusion. If your publication record, citation count, and awards are solid, an independent second opinion is worth getting before concluding EB-1B isn't available.
Yes, and MSK researchers commonly do this. MSK files the EB-1B I-140; you file the EB-1A I-140 through outside counsel independently. Two I-140s can be pending simultaneously for the same beneficiary. If the EB-1A is approved first and the priority date is current, you can file I-485 without waiting for the EB-1B. Both priority dates are protected simultaneously.
Standard processing at Nebraska Service Center: 6–12 months. Premium processing (I-907): 15 business days. Priority dates for EB-1 (covering EB-1B): current for most nationalities; Indian nationals should monitor the Visa Bulletin. After I-140 approval with a current priority date, adjustment of status adds 12–24 months. NYC researchers who are cap-exempt on H-1B or J-1 can remain in status throughout without disruption.
